Ирска - Енглески - HPRA (Health Products Regulatory Authority)

sol s.p.a. - oxygen - medicinal gas, compressed - 100 percent volume/volume - medical gases; oxygen

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - air, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - for normal respiration. in anaesthetic equipment as a carrier gas during surgery. for nebulisation of inhaled drugs when oxygen supplementation is not required.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - nitrous oxide, quantity: 1 l/l - gas, medicinal - excipient ingredients: - indications as at 1 november 2001: nitrous oxide is indicated in adults and children for: 1. general anaesthesia, usually as an adjuvant to other volatile or intravenous anaesthetics; 2. analgesia (with oxygen) eg. dentistry and obstetrics.

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

boc gases ireland ltd - oxygen - medicinal gas, compressed - 99.5 percent volume/volume - medical gases; oxygen

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

air liquide healthcare ireland limited - oxygen - medicinal gas, compressed - 100 percent volume/volume - medical gases; oxygen

Европска Унија - Енглески - EMA (European Medicines Agency)

lipomed gmbh - deferiprone - iron overload; beta-thalassemia - all other therapeutic products - deferiprone lipomed monotherapy is indicated for the treatment of iron overload in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate.deferiprone lipomed in combination with another chelator is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload justifies rapid or intensive correction.

Европска Унија - Енглески - EMA (European Medicines Agency)

lipomed gmbh - thalidomide - multiple myeloma - immunosuppressants - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy.thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.4).

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

boc gases ireland ltd - oxygen - medicinal gas, cryogenic - 99.5 percent volume/volume - medical gases; oxygen

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

sol s.p.a. - oxygen - medicinal gas, compressed - 21.75 percent volume/volume - medical gases; oxygen

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - doxycycline hyclate, quantity: 116.3 mg (equivalent: doxycycline, qty 100 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; purified water; hypromellose phthalate; povidone; diethyl phthalate; magnesium stearate; wheat starch; hypromellose; lactose monohydrate; hyprolose; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - doxycycline is primarily bacteriostatic and is thought to exert its antimicrobial effect by the inhibition of protein synthesis. doxycycline is active against a wide range of gram-positive and gram-negative organisms. note: the 50 mg capsule is not a paediatric formulation. mayne pharma doxycycline capsules are indicated in the treatment of infections caused by the following micro-organisms: mycoplasma pneumoniae: primary atypical pneumonia. rickettsiae: queensland tick typhus, typhus fever and q fever. agents of psittacosis. calymmatobacterium (donovania) granulomitis: granuloma inguinale. agents of lymphogranuloma venereum. borreliae: relapsing fever. chlamydia trachomatis. mayne pharma doxycycline capsules are indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline capsules alone, or in combination with topical agents. mayne pharma doxycycline is indicated in the treatment of infections caused by the following gram-negative micro-organisms: vibrio species: cholera. brucella species: brucellosis (in conjunction with streptomycin). yersinia pestis: plague. francisella tularensis: tularemia. bartonella bacilliformis: bartonellosis. bacteroides species. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum: syphilis. treponema pertenue: yaws. neisseria gonorrhoea: gonorrhoea (see dosage and administration). mayne pharma doxycycline capsules is not the drug of choice in the treatment of any type of staphylococcal infection or infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, streptococcus faecalis, or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxycycline should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory tract infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever) penicillin is the usual drug of choice. doxycycline is active against both pre-erythroycitic and asexual bloodstages of plasmodium falciparum. the tetracyclines are only partially active against the pre-erythrocytic stages of plasmodium vivax and protection depends on drug suppression of the blood stages. doxycycline has no activity against the relapsing forms (hypnozoites) of plasmodium vivax. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example chloroquine. in acute intestinal amoebiasis mayne pharma doxycycline capsules may be a useful adjunct to amoebicides. in severe acne mayne pharma doxycycline capsules may be a useful adjunctive therapy.